# Sustained Release Lidocaine for the Treatment of Postoperative Pain

> **NCT05193227** · PHASE2 · RECRUITING · sponsor: **University of British Columbia** · enrollment: 120 (estimated)

## Conditions studied

- Postoperative Pain
- Postsurgical Pain

## Interventions

- **DRUG:** ST-01
- **DRUG:** Control (Lidocaine Hydrochloride Injection USP Xylocaine® or Bupivacaine Hydrochloride Injection USP Marcaine®)

## Key facts

- **NCT ID:** NCT05193227
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-10-27
- **Primary completion:** 2026-04-27
- **Final completion:** 2026-05-27
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-02-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05193227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05193227, "Sustained Release Lidocaine for the Treatment of Postoperative Pain". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05193227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*